查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1835532

醫療影像模型市場（按產品類型、材料、應用和最終用戶分類）—全球預測 2025-2032

Medical Imaging Phantoms Market by Product Type, Material, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫學影像模型市場規模將成長至 3.4361 億美元，複合年成長率為 6.92%。

主要市場統計數據
基準年2024年 2.0112億美元
預計2025年 2.1535億美元
預測年份：2032年 3.4361億美元
複合年成長率（%） 6.92%

醫學影像模型的全面基礎概述突顯了技術發展、臨床作用、檢驗要求和相關人員的策略重點

醫學影像模型是診斷和介入工作流程中必不可少的工具，它連接著技術開發、臨床檢驗和操作員培訓。這些人工構建體能夠複製解剖結構、組織特性和放射學反應，為設備校準、成像通訊協定檢驗和跨學科團隊培訓提供可重複和檢驗的條件。隨著顯像模式在解析度、速度和功能方面的不斷發展，模型的作用正從簡單的幾何物件擴展到反映現代臨床需求的複雜多模態測試物件。

在這種環境下，從設備製造商到臨床終端使用者的相關人員紛紛轉向使用體模，以降低風險、加快法規核准並最佳化規模化效能。過去十年，材料科學和製造技術的進步使得更忠實地模擬組織異質性、分子造影行為和聲學特性。因此，體模已深度融入研究流程和常規品質保證計劃。以下分析總結了這些動態，並為尋求了解體模生態系統中當前優先事項、新興機會和營運考慮的領導者提供了簡潔的指導。

深入分析重塑幻影格局的關鍵轉型變化，包括積層製造、人工智慧驗證、材料科學和監管融合

醫學影像模型的領域正在經歷數次變革，技術發展軌跡和商業性重點也隨之改變。積層製造技術能夠快速迭代以前無法實現的複雜形態和內部結構，使開發人員能夠更快地製作原型並檢驗特定於設備的功能。同時，先進材料，尤其是那些能夠更好地模擬介電、聲學和放射密度特性的材料，使模型能夠展現混合成像平台所需的多物理場行為。

同時，數據驅動的方法正在影響檢驗過程。用於影像重建和解讀的機器學習模型需要多樣化、註釋的資料集來進行穩健的訓練和效能評估。這項要求促使人們設計體模，以產生跨模態的可重複、可量化的真實數據。監管和臨床相關人員也在就標準化測試通訊協定達成共識，從而提升了經過認證的可重複體模的價值。最後，供應鏈透明度和永續性考量如今指南採購決策，鼓勵製造商最佳化材料採購和生命週期影響。總而言之，這些轉變正在創造一個由技術創新、檢驗嚴謹性和營運彈性決定競爭優勢的格局。

研究 2025 年美國關稅對整個 Phantom 生態系統的供應鏈籌資策略和製造本地化決策的累積影響

2025年美國關稅的實施，對影像模型製造商及其買家的全球供應鏈和籌資策略造成了直接壓力。某些進口零件和原料的關稅上調，促使企業重新評估其供應商佈局，評估近岸外包選項，並加快替代供應商的資格審查流程。由於買家進行了額外的合規性檢查，並試圖了解現有採購安排對總到岸成本的影響，實際採購週期暫時延長。

作為應對，製造商加大了關鍵工藝的本地化力度，尤其是那些受關稅影響最大的精密加工、成型和材料複合工藝。此類調整通常需要投資國內產能，或在低風險地區取得二級供應商的資格。重要的是，關稅環境強調合約靈活性和庫存策略作為戰術性槓桿。擁有快速反應的物流和多元化供應商關係的企業更有可能保持供應的連續性並保障產品開發進度。展望未來，關稅將成為更穩健供應鏈設計的催化劑，而非永久轉向保護主義。

深入的細分綜合揭示了產品類型、材料科學應用重點和最終用戶行為如何與工程選擇、採購動態和服務模式融合

細分分析揭示了產品類型差異化、材料選擇、應用重點和最終用戶特徵如何影響開發優先順序和購買行為。在產品類型中，電腦斷層掃描專用模型優先考慮高對比度病變模擬和衰減精度，而磁共振模型則強調弛豫參數保真度和磁化率控制。核子醫學影像模型需要精確的放射性分佈和衰減特性，而PET模型必須考慮符合率和正微波效應。超音波模型需要高度可重複的聲電阻和背向散射特性，X光模型必須在幾何保真度和放射密度校準需求之間取得平衡。因此，每種產品類型都需要製造商必須解決的獨特工程權衡和檢驗通訊協定。

材料選擇進一步影響性能範圍和生命週期特性。丙烯酸和環氧樹脂系統可提供穩定、可加工的平台，適合長期品質保證工作；而水凝膠配方則具有類似組織的柔軟度和頻率相關的聲學特性，適用於超音波應用。塑膠複合材料和彈性體/橡膠可實現靈活的配置和可重複的機械響應，使其成為培訓和模擬模組的必備材料。材料特性與應用（無論是設備檢驗、品質保證、研究、培訓或教育）之間的相互作用決定了可接受的公差、老化特性和維護要求。

按應用細分凸顯了不同的價值提案。設備測試和品質保證需要嚴格的可重複性和可追溯的校準標準，強調長期穩定性和可認證的性能。研究應用通常需要可自訂的模組化模型，允許控制參數變化以支持假設驅動的研究。訓練和教育優先考慮人體工學的真實性、經濟高效的可重複性和可重複使用的安全操作。最後，最終用戶表現出不同的購買行為。學術和研究機構通常優先考慮實驗設置和數據訪問，診斷中心優先考慮操作可靠性和吞吐量，醫院優先考慮跨專業適用性和法規遵從性，而製藥公司則需要支援成像生物標記檢驗和測試可重複性的模型。了解這些相交的細分軸可以使有針對性的產品策略和服務模式與相關人員的特定優先事項保持一致。

美洲、歐洲、中東和非洲以及亞太地區的戰略洞察揭示了採用促進因素、監管重點、製造優勢和採購模式

區域動態對整個模型領域的技術採用、監管預期和製造策略有重大影響。在美洲，研發中心和成熟的臨床基礎設施正在推動對高保真度、合規模型的需求，這些模型既支援設備驗證，也支援臨床培訓計畫。該地區的採購流程越來越注重合規性文件、國內供應的連續性和供應商的透明度，這使得提供認證產品和快速售後服務的製造商受益。

在歐洲、中東和非洲，監管協調和對臨床標準化的重視為支持跨境驗證和多中心測試的體模創造了機會。在歐洲市場，永續性和生命週期報告通常被優先考慮，鼓勵供應商記錄材料的來源及其使用後的管道。相較之下，中東和非洲的臨床成熟度和基礎設施需求水準參差不齊，因此對可擴展且經濟高效的體模的需求強勁，以配合培訓和基本的品質保證計畫。

亞太地區臨床應用的快速發展與強大的製造能力相結合，使其成為模體技術的主要消費和生產地。該地區在精密製造和材料加工方面的能力支撐著區域供應鏈，而對大型成像網路和研究項目的投資則刺激了對先進的、特定於醫療器材的模體的需求。排放和供應鏈韌性等區域優先事項正日益影響採購框架，鼓勵製造商展示技術性能和環境管理能力。

推動競爭優勢和長期客戶關係的創新重點夥伴關係策略認證和服務差異化主要企業的競爭考察

公司層面的動態揭示了市場參與企業中幾個反覆出現的策略主題。首先，創新週期擴大圍繞著材料工程和製造靈活性。領導者正在投資專有複合材料和製造方法，以實現快速客製化，同時保持檢驗的完整性。其次，與臨床中心和設備原始設備製造商的夥伴關係加速了產品的改進，並方便取得能夠證明實際性能的檢驗數據。這些合作管道縮短了開發和臨床驗收之間的回饋循環。

第三，服務和認證管道能夠帶來顯著的差異化。將全面的校準服務、技術培訓計畫和記錄在案的驗證通訊協定融入其產品的公司，能夠增強客戶維繫並創造經常性收益來源。最後，供應鏈管理和品質系統的卓越運作仍然至關重要，尤其是在受監管的司法管轄區。保持清晰的可追溯性、強大的變更管理和響應迅速的售後服務的公司更有可能與大型醫療保健系統和跨國研究聯盟簽訂長期合約。

產業領導者應採取實際行動，加強供應鏈彈性，加速材料創新，擴大臨床夥伴關係，拓寬以服務為基礎的差異化

行業領導者可以在多個方面採取果斷行動，以確保永續成長並降低新興風險。首先，他們應優先考慮供應鏈多元化，透過評估互補地區的多家供應商，並選擇性地投資關鍵零件的近岸生產能力。這些措施將在保持開發彈性的同時，降低貿易政策波動所帶來的風險。其次，他們正在加快對材料研發和積層製造能力的投資，以實現更高保真度、與模態無關的模型，並縮短客製化應用的設計週期。

第三，我們將深化臨床夥伴關係，共同製定驗證通訊協定，並將模型納入早期設備測試和訓練課程。第四，我們將透過整合技術培訓、校準和資料打包來增強我們的服務，從而為最終用戶縮短部署時間並降低操作複雜性。第五，我們將積極與監管和標準組織合作，以影響測試方法，並確保新產品符合不斷變化的需求。最後，我們將在材料採購和包裝方面採用可衡量的永續性實踐，以滿足日益成長的採購預期，並減少生命週期的環境影響。

透明而嚴謹的調查方法，描述了用於確保可靠性和有效性的主要訪談、技術檢驗、文獻綜合、同行評審和三角測量技術

本分析所依據的調查方法結合了質性與技術方法，以確保嚴謹性和有效性。主要證據來自對臨床醫生、採購負責人、技術總監和材料科學家的結構化訪談，從而提供對性能預期和操作限制的背景理解。二級資訊來源包括同行評審文獻、標準文件和技術白皮書，這些資料有助於深入了解驗證實踐和材料性能特徵。

技術檢驗包括實驗室評估和供應商能力評估，以檢驗關於材料穩定性、尺寸精度和模態相容性的聲明。跨資料流（訪談、技術檢查和文獻）的三角測量支持對趨勢的穩健解讀，並減少單一來源偏差。在此過程中，專家小組審查了初步研究結果，以確認其實際相關性並突出需要進一步研究的領域。調查方法認知到快速發展的技術的固有局限性，並建議定期重新評估以捕捉快速的創新週期。

簡要總結結論，強調了對材料檢驗供應鏈彈性、監管協調和臨床夥伴關係進行全面投資的必要性。

總而言之，醫學影像體模領域正處於曲折點，材料創新、製造敏捷性和以服務主導的差異化將決定策略成果。體模在設備驗證、臨床培訓和演算法效能評估中發揮越來越重要的作用，而圍繞特定醫療模式需求和最終用戶工作流程設計產品的相關人員正獲得更廣泛的應用。供應鏈彈性和監管合規性與技術卓越性相輔相成，構成了規模化營運所需的基礎。

因此，決策者應該專注於將技術創新與強大的驗證、敏捷的供應鏈設計和強大的臨床夥伴關係關係相結合的整合策略，以便組織不僅可以解決短期中斷，還可以獲得具有可重複性能、監管準備和明顯營運優勢的解決方案所帶來的長期價值。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 擴大採用針對患者的 3D 列印模型來確保個人化放射治療的質量
  • 增強人工智慧驅動的圖像模型整合，以標準化 CT 和 MRI 性能指標
  • 開發與 MRI、CT、超音波和 PET 相容的綜合多模態成像模型，用於掃描儀校準
  • 人們對模仿兒科解剖結構的擬人模型的需求日益成長，以最佳化兒科影像的劑量管理。
  • 用於建構高保真超音波和彈性成像模型的仿生組織等效材料的進展
  • 擴展虛擬和數位模型平台，用於影像重建演算法檢驗和臨床工作流程培訓
  • 學術研究機構和製造商合作設計用於新模態測試的可自訂模型
  • 監管重點是標準化的基於模型的品管通訊協定，以確保各中心之間可重複的成像性能

第6章 2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 醫療影像模型市場（依產品類型）

  • CT體模
  • MRI體模
  • 核子成像體模
  • PET體模
  • 超音波模
  • X光模型

9. 醫學影像模型市場（按材料）

  • 丙烯酸纖維
  • 環氧樹脂
  • 水凝膠
  • 塑膠
  • 橡皮

第 10 章：醫學影像模型市場（按應用）

  • 設備測試
  • 品質保證
  • 研究
  • 培訓和教育

第 11 章 醫學影像模型市場（依最終使用者）

  • 學術研究機構
  • 診斷中心
  • 醫院
  • 製藥公司

12. 醫學影像模型市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 醫學影像模式市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國醫學影像模型市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Computerized Imaging Reference Systems, Inc.
    • Sun Nuclear Corporation
    • Standard Imaging, Inc.
    • Kyoto Kagaku Co., Ltd.
    • Modus Medical Devices Inc.
    • PTW-Freiburg GmbH
    • Phantom Laboratory, Inc.
    • Tissue Simulation Technology, LLC
    • Radiation Imaging Technology, Inc.
    • Fluke Biomedical
Product Code: MRR-0363DFE03664

The Medical Imaging Phantoms Market is projected to grow by USD 343.61 million at a CAGR of 6.92% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 201.12 million
Estimated Year [2025] USD 215.35 million
Forecast Year [2032] USD 343.61 million
CAGR (%) 6.92%

Comprehensive foundational overview of medical imaging phantoms that clarifies technological evolution clinical roles validation requirements and strategic priorities for stakeholders

Medical imaging phantoms serve as indispensable instruments bridging technology development, clinical validation, and operator training across diagnostic and interventional workflows. These engineered constructs replicate anatomical structures, tissue properties, and radiological responses to provide repeatable, verifiable conditions for calibrating devices, validating imaging protocols, and educating multidisciplinary teams. As imaging modalities evolve in resolution, speed, and functionality, the role of phantoms expands beyond simple geometric targets to complex, multimodal test objects that reflect the demands of contemporary clinical practice.

Within this context, stakeholders ranging from device manufacturers to clinical end users rely on phantoms to reduce risk, accelerate regulatory clearance, and optimize performance at scale. Over the past decade, improvements in materials science and manufacturing techniques have enabled higher-fidelity simulation of tissue heterogeneity, molecular contrast behavior, and acoustic properties. Consequently, phantoms now support deeper integration into research pipelines and routine quality assurance programs. The following analysis synthesizes these dynamics to provide a succinct orientation for leaders seeking to understand immediate priorities, emerging opportunities, and operational considerations in the phantom ecosystem.

Detailed analysis of the major transformative shifts reshaping the phantom landscape including additive manufacturing AI validation materials science and regulatory convergence

Several transformative shifts are actively reshaping the landscape for medical imaging phantoms, altering both technological trajectories and commercial priorities. Additive manufacturing now enables rapid iteration of complex geometries and internal structures that were previously infeasible, and as a result, developers can prototype and validate modality-specific features with greater speed. At the same time, advanced materials-particularly those that better mimic dielectric, acoustic, or radiodensity properties-allow phantoms to exhibit multi-physics behavior required for hybrid imaging platforms.

Concurrently, data-driven approaches influence validation processes; machine learning models used in image reconstruction and interpretation demand diverse, annotated datasets for robust training and performance evaluation. This requirement incentivizes phantoms designed to produce reproducible, quantifiable ground truth across modalities. Regulatory and clinical stakeholders are also converging on standardized test protocols, which increases the value of certified, repeatable phantoms. Finally, supply chain transparency and sustainability considerations now guide procurement decisions, encouraging manufacturers to optimize material sourcing and lifecycle impacts. Taken together, these shifts create a landscape in which innovation, validation rigor, and operational resiliency determine competitive advantage.

Examination of the cumulative effects of United States tariff actions from 2025 on supply chains procurement strategies and manufacturing localization decisions across the phantom ecosystem

The introduction of United States tariff measures in 2025 created immediate pressure on global supply chains and procurement strategies for imaging phantom manufacturers and their purchasers. Elevated duties on certain imported components and raw materials prompted firms to reassess supplier footprints, evaluate nearshoring options, and accelerate qualification processes for alternative vendors. In practice, procurement cycles lengthened temporarily as buyers implemented additional compliance checks and sought to understand the total landed cost implications of existing sourcing arrangements.

In response, manufacturers intensified efforts to localize critical processes, particularly those involving high-precision machining, molding, and materials compounding where tariff exposure was most acute. These adjustments often required investments in domestic capacity or the qualification of secondary suppliers in lower-risk jurisdictions. Importantly, the tariff environment has emphasized contractual flexibility and inventory strategy as tactical levers; organizations that maintain responsive logistics and diversified supplier relationships tend to preserve continuity of supply and protect product development timelines. Moving forward, tariffs serve as a catalyst for more robust supply chain design rather than a permanent shift toward protectionism.

In-depth segmentation synthesis revealing how product type material science application focus and end-user behavior converge to dictate engineering choices procurement dynamics and service models

Segmentation analysis illuminates how product type differentiation, material selection, application focus, and end user characteristics shape development priorities and purchasing behavior. Within product typologies, computed tomography-specific phantoms prioritize high-contrast lesion simulation and attenuation accuracy while magnetic resonance phantoms emphasize relaxation parameter fidelity and susceptibility control. Nuclear imaging phantoms require precise activity distribution and attenuation characteristics, whereas PET phantoms must account for coincident event rates and positron range effects. Ultrasound phantoms demand reproducible acoustic impedance and backscatter properties, and X-ray phantoms balance geometric fidelity with radiodensity calibration needs. Each product type therefore drives unique engineering trade-offs and validation protocols that manufacturers must accommodate.

Material choices further influence performance envelopes and lifecycle characteristics. Acrylic and epoxy systems provide stable, machinable platforms suitable for long-term QA tasks, while hydrogel formulations offer tissue-like softness and frequency-dependent acoustic behavior for ultrasound applications. Plastic composites and elastomeric rubbers enable flexible geometries and repeatable mechanical responses, which can be essential for training and simulation modules. The interplay between material properties and intended application-whether equipment testing, quality assurance, research, or training and education-determines acceptable tolerances, aging characteristics, and maintenance requirements.

Application-driven segmentation highlights distinct value propositions. Equipment testing and quality assurance demand rigorous repeatability and traceable calibration standards, emphasizing long-term stability and certifiable performance. Research applications often need customizable, modular phantoms that permit controlled variation of parameters to support hypothesis-driven studies. Training and education prioritize ergonomic realism, cost-effective reproducibility, and safe handling for repeated use. Finally, end users exhibit differentiated procurement behaviors: academic and research institutes typically value configurability and data access for experimentation, diagnostic centers focus on operational reliability and throughput, hospitals emphasize cross-specialty applicability and regulatory compliance, and pharmaceutical companies require phantoms that support imaging biomarker validation and trial reproducibility. Understanding these intersecting segmentation axes enables targeted product strategies and service models that align with stakeholder-specific priorities.

Strategic regional insights across the Americas Europe Middle East and Africa and Asia-Pacific that highlight adoption drivers regulatory priorities manufacturing strengths and procurement patterns

Regional dynamics exert a profound influence on technology adoption, regulatory expectations, and manufacturing strategy across the phantom landscape. In the Americas, innovation centers and established clinical infrastructures drive demand for high-fidelity, regulatory-aligned phantoms that support both device validation and clinical training programs. Procurement processes in this region increasingly emphasize compliance documentation, domestic supply continuity, and vendor transparency, which benefit manufacturers offering certified products and responsive aftermarket services.

Across Europe, the Middle East and Africa, regulatory harmonization efforts and a strong emphasis on clinical standardization create opportunities for phantoms that support cross-border validation and multi-center studies. European markets often prioritize sustainability and lifecycle reporting, encouraging suppliers to document material provenance and end-of-life pathways. In contrast, the Middle East and Africa present a diverse set of clinical maturity levels and infrastructure needs, where scalable, cost-efficient phantoms tailored to training and basic QA programs find strong demand.

Asia-Pacific combines rapid clinical adoption with substantial manufacturing capability, positioning the region as both a major consumer and producer of phantom technologies. Local capabilities in precision manufacturing and materials processing support regional supply chains, while investments in large-scale imaging networks and research initiatives stimulate demand for advanced, modality-specific phantoms. Regional policy priorities, including emissions reduction and supply chain resilience, increasingly shape procurement frameworks and encourage manufacturers to demonstrate both technical performance and environmental stewardship.

Key company insights capturing innovation priorities partnership strategies certification and service differentiation that drive competitive advantage and long-term customer relationships

Company-level dynamics reveal several recurring strategic themes among market participants. First, innovation cycles increasingly revolve around materials engineering and manufacturing flexibility; leaders invest in proprietary composites and fabrication methods that enable rapid customization while preserving validation integrity. Second, partnerships with clinical centers and device OEMs accelerate product refinement and facilitate access to validation data that demonstrate real-world performance. These collaborative pathways shorten feedback loops between development and clinical acceptance.

Third, services and certification pathways offer meaningful differentiation. Companies that couple products with comprehensive calibration services, technical training programs, and documented validation protocols strengthen customer retention and generate recurring revenue streams. Finally, operational excellence in supply chain management and quality systems-especially in regulated jurisdictions-remains a critical factor. Firms that maintain clear traceability, robust change control, and responsive after-sales support tend to secure long-term contracts with large healthcare systems and multinational research consortia.

Practical actionable recommendations for industry leaders to strengthen supply chain resilience accelerate materials innovation expand clinical partnerships and scale service-based differentiation

Industry leaders can act decisively on several fronts to secure sustainable growth and mitigate emerging risks. First, prioritize diversification of supply chains by qualifying multiple suppliers across complementary geographies and by investing selectively in nearshore capabilities for mission-critical components. Such steps reduce exposure to trade policy volatility while preserving development agility. Second, accelerate investment in materials R&D and additive manufacturing capacity to enable higher-fidelity, modality-agnostic phantoms and to shorten design cycles for bespoke applications.

Third, deepen clinical partnerships to co-develop validation protocols and to embed phantoms into early-stage device testing and training curricula; this approach fosters product-market fit and supports adoption. Fourth, enhance service offerings by bundling technical training, calibration, and data packages that demonstrably reduce onboarding time and operational complexity for end users. Fifth, engage proactively with regulatory and standards bodies to influence test methodologies and to ensure that new products align with evolving requirements. Finally, adopt measurable sustainability practices across material sourcing and packaging to meet increasing procurement expectations and to reduce lifecycle environmental impacts.

Transparent and rigorous research methodology describing primary interviews technical validation literature synthesis expert review and triangulation techniques used to ensure reliability and relevance

The research methodology underpinning this analysis combines qualitative and technical approaches to ensure rigor and relevance. Primary evidence comes from structured interviews with clinicians, procurement officers, engineering leads, and materials scientists, which provide contextual understanding of performance expectations and operational constraints. Secondary sources include peer-reviewed literature, standards documentation, and technical white papers that illuminate validation practices and material performance characteristics.

Technical validation involved laboratory evaluations and supplier capability assessments to verify claims about material stability, dimensional accuracy, and modality compatibility. Triangulation across data streams-interviews, technical tests, and literature-supported robust interpretation of trends and reduced single-source bias. Throughout the process, expert panels reviewed draft findings to ensure practical relevance and to highlight areas requiring further investigation. The methodology acknowledges limitations inherent to fast-evolving technologies and recommends periodic reassessment to capture rapid innovation cycles.

Concise concluding synthesis stressing the imperative for integrated investment in materials validation supply chain resilience regulatory alignment and clinical partnerships

In conclusion, the medical imaging phantom sector stands at an inflection point where materials innovation, manufacturing agility, and service-led differentiation determine strategic outcomes. Phantoms increasingly serve as critical enablers for device validation, clinical training, and algorithmic performance assessment, and stakeholders that align product design with modality-specific needs and end-user workflows realize greater adoption. Supply chain resilience and regulatory alignment complement technical excellence, forming the operational foundation necessary for scale.

Decision-makers should therefore focus on integrated strategies that combine technical innovation with robust validation, responsive supply chain design, and strong clinical partnerships. By doing so, organizations can not only manage near-term disruptions but also position themselves to capture the long-term value that accrues to solutions demonstrating repeatable performance, regulatory readiness, and clear operational benefit.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of patient-specific 3D printed phantoms for personalized radiation therapy quality assurance
  • 5.2. Increasing integration of artificial intelligence-driven imaging phantoms to standardize CT and MRI performance metrics
  • 5.3. Development of multimodal imaging phantoms compatible with MRI, CT, ultrasound and PET for comprehensive scanner calibration
  • 5.4. Growing demand for anthropomorphic phantoms simulating pediatric anatomies to optimize dose management in pediatric imaging
  • 5.5. Advancements in biomimetic tissue-equivalent materials for high fidelity ultrasound and elastography phantom construction
  • 5.6. Expansion of virtual and digital phantom platforms for image reconstruction algorithm validation and clinical workflow training
  • 5.7. Collaboration between academic research institutions and manufacturers to design customizable phantoms for novel modality testing
  • 5.8. Regulatory emphasis on standardized phantom-based quality control protocols to ensure reproducible imaging performance across facilities

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Imaging Phantoms Market, by Product Type

  • 8.1. CT Phantom
  • 8.2. MRI Phantom
  • 8.3. Nuclear Imaging Phantom
  • 8.4. Pet Phantom
  • 8.5. Ultrasound Phantom
  • 8.6. X-Ray Phantom

9. Medical Imaging Phantoms Market, by Material

  • 9.1. Acrylic
  • 9.2. Epoxy
  • 9.3. Hydrogel
  • 9.4. Plastic
  • 9.5. Rubber

10. Medical Imaging Phantoms Market, by Application

  • 10.1. Equipment Testing
  • 10.2. Quality Assurance
  • 10.3. Research
  • 10.4. Training & Education

11. Medical Imaging Phantoms Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals
  • 11.4. Pharmaceutical Companies

12. Medical Imaging Phantoms Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Medical Imaging Phantoms Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Medical Imaging Phantoms Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Computerized Imaging Reference Systems, Inc.
    • 15.3.2. Sun Nuclear Corporation
    • 15.3.3. Standard Imaging, Inc.
    • 15.3.4. Kyoto Kagaku Co., Ltd.
    • 15.3.5. Modus Medical Devices Inc.
    • 15.3.6. PTW-Freiburg GmbH
    • 15.3.7. Phantom Laboratory, Inc.
    • 15.3.8. Tissue Simulation Technology, LLC
    • 15.3.9. Radiation Imaging Technology, Inc.
    • 15.3.10. Fluke Biomedical

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. MEDICAL IMAGING PHANTOMS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. MEDICAL IMAGING PHANTOMS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MEDICAL IMAGING PHANTOMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY CT PHANTOM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY CT PHANTOM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY CT PHANTOM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY CT PHANTOM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY CT PHANTOM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY CT PHANTOM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MRI PHANTOM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MRI PHANTOM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MRI PHANTOM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MRI PHANTOM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MRI PHANTOM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MRI PHANTOM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY NUCLEAR IMAGING PHANTOM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY NUCLEAR IMAGING PHANTOM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY NUCLEAR IMAGING PHANTOM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY NUCLEAR IMAGING PHANTOM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY NUCLEAR IMAGING PHANTOM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY NUCLEAR IMAGING PHANTOM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PET PHANTOM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PET PHANTOM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PET PHANTOM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PET PHANTOM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PET PHANTOM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PET PHANTOM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ULTRASOUND PHANTOM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ULTRASOUND PHANTOM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ULTRASOUND PHANTOM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ULTRASOUND PHANTOM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ULTRASOUND PHANTOM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ULTRASOUND PHANTOM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY X-RAY PHANTOM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY X-RAY PHANTOM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY X-RAY PHANTOM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY X-RAY PHANTOM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY X-RAY PHANTOM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY X-RAY PHANTOM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACRYLIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACRYLIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACRYLIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACRYLIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACRYLIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACRYLIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EPOXY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EPOXY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EPOXY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EPOXY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EPOXY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EPOXY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HYDROGEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HYDROGEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HYDROGEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HYDROGEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HYDROGEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RUBBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RUBBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RUBBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RUBBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RUBBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RUBBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EQUIPMENT TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EQUIPMENT TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EQUIPMENT TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EQUIPMENT TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EQUIPMENT TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY EQUIPMENT TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY QUALITY ASSURANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY QUALITY ASSURANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY QUALITY ASSURANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY QUALITY ASSURANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY QUALITY ASSURANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY QUALITY ASSURANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 184. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. MIDDLE EAST MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 194. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 195. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. AFRICA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 216. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 217. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. ASEAN MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 226. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 227. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. GCC MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPEAN UNION MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 246. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 247. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. BRICS MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 256. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 257. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. G7 MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 266. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 267. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. NATO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 276. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 277. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 279. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED STATES MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 284. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 285. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. CANADA MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 292. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 293. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. MEXICO MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 300. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 301. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. BRAZIL MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 308. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 309. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. UNITED KINGDOM MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 316. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 317. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 320. GERMANY MEDICAL IMAGING PHANTOMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 321. FRANCE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. FRANCE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. FRANCE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 324. FRANCE MEDICAL IMAGING PHANTOMS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 325. FRANCE MEDICAL IMAGING PHANTOMS MARKET SIZE, B